Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Intermittent Claudication”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Early research (Phase 1)Study completedNCT00523731
What this trial is testing

ACPs in Severe PAD/CLI by Direct Intramuscular Injection

Who this might be right for
Peripheral Arterial DiseaseCritical Limb Ischemia
TheraVitae Ltd. 6
Early research (Phase 1)UnknownNCT00311805
What this trial is testing

Autologous CD34+ Stem Cell Injection for Severe Intermittent Claudication (Leg Pain)

Who this might be right for
Peripheral Artery DiseaseSevere Intermittent Claudication
Losordo, Douglas, M.D. 24
Not applicableStudy completedNCT06234280
What this trial is testing

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease

Who this might be right for
Symptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)
Yonsei University 100
Post-approval studies (Phase 4)Study completedNCT00906022
What this trial is testing

Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty (PTA) With Optional Bailout Stenting in Case of PTA Failure in Patients With Symptomatic Critical Limb Ischemia or Severe Intermittent Claudication (EXPAND)

Who this might be right for
Patients With Symptomatic Critical Limb IschemiaSevere Intermittent Claudication
Biotronik AG 94
Not applicableUnknownNCT03505931
What this trial is testing

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)

Who this might be right for
Symptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)
Yonsei University 100